اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است
CADUET از شرکت PHARMACIA
New Drug Application (NDA): 021540
Company: PHARMACIA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | Yes |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription |
AB |
Yes | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/30/2004 | ORIG-1 | Approval |
Type 4 – New Combination |
STANDARD |
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540_caduet_lbl.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 09/25/2020 | SUPPL-48 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540s048lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021540Orig1s048ltr.pdf |
||
| 12/15/2020 | SUPPL-47 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540Orig1s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021540Orig1s047ltr.pdf |
||
| 01/07/2021 | SUPPL-46 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021540s046lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021540Orig1s046ltr.pdf |
||
| 12/18/2019 | SUPPL-45 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021540s045lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021540Orig1s045ltr.pdf |
||
| 05/10/2019 | SUPPL-44 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020540s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021540Orig1s044ltr.pdf |
||
| 09/12/2018 | SUPPL-43 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021540Orig1s042,021540Orig1s043REPLACEMENTltr.pdf |
||
| 09/12/2018 | SUPPL-42 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021540Orig1s042,021540Orig1s043REPLACEMENTltr.pdf |
||
| 05/25/2018 | SUPPL-41 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s041lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021540Orig1s041ltr.pdf |
||
| 06/23/2017 | SUPPL-39 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021540Origs039ltr.pdf |
||
| 10/30/2017 | SUPPL-38 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s038lbl.pdf |
||
| 02/17/2015 | SUPPL-37 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021540Orig1s037ltr.pdf |
||
| 03/23/2015 | SUPPL-36 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021540Orig1s036ltr.pdf |
||
| 07/28/2014 | SUPPL-35 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 05/22/2014 | SUPPL-34 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021540s034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021540Orig1s034ltr.pdf |
||
| 04/21/2014 | SUPPL-33 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 11/07/2013 | SUPPL-31 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021540Orig1s030,s031ltr.pdf |
||
| 11/07/2013 | SUPPL-30 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021540Orig1s030,s031ltr.pdf |
||
| 07/31/2013 | SUPPL-29 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 10/31/2012 | SUPPL-28 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021540Orig1s028ltr.pdf |
||
| 07/26/2012 | SUPPL-26 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021540Orig1s023,s026ltr.pdf |
||
| 07/26/2012 | SUPPL-23 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021540Orig1s023,s026ltr.pdf |
||
| 02/17/2010 | SUPPL-19 | Labeling-Package Insert |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021540s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021540s019ltr.pdf |
||
| 07/20/2009 | SUPPL-18 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021540s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021540s018ltr.pdf |
||
| 05/29/2008 | SUPPL-14 | Labeling |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021540s014ltr.pdf |
|
| 09/20/2007 | SUPPL-11 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021540s011ltr.pdf |
||
| 09/20/2007 | SUPPL-9 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021540s009ltr.pdf |
||
| 04/13/2006 | SUPPL-8 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021540s008ltr.pdf |
||
| 08/28/2006 | SUPPL-6 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021540s006ltr.pdf |
||
| 09/27/2004 | SUPPL-3 | Labeling |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21540s003ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 01/07/2021 | SUPPL-46 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021540s046lbl.pdf | |
| 12/15/2020 | SUPPL-47 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540Orig1s047lbl.pdf | |
| 09/25/2020 | SUPPL-48 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021540s048lbl.pdf | |
| 12/18/2019 | SUPPL-45 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021540s045lbl.pdf | |
| 05/10/2019 | SUPPL-44 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020540s044lbl.pdf | |
| 09/12/2018 | SUPPL-43 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf | |
| 09/12/2018 | SUPPL-42 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s042s043lbl.pdf | |
| 05/25/2018 | SUPPL-41 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021540s041lbl.pdf | |
| 10/30/2017 | SUPPL-38 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s038lbl.pdf | |
| 06/23/2017 | SUPPL-39 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021540s039lbl.pdf | |
| 03/23/2015 | SUPPL-36 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s036lbl.pdf | |
| 02/17/2015 | SUPPL-37 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021540s037lbl.pdf | |
| 05/22/2014 | SUPPL-34 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021540s034lbl.pdf | |
| 11/07/2013 | SUPPL-31 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf | |
| 11/07/2013 | SUPPL-30 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021540s030s031lbl.pdf | |
| 10/31/2012 | SUPPL-28 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s028lbl.pdf | |
| 07/26/2012 | SUPPL-26 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf | |
| 07/26/2012 | SUPPL-23 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021540s023s026lbl.pdf | |
| 02/17/2010 | SUPPL-19 |
Labeling-Package Insert |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021540s019lbl.pdf | |
| 07/20/2009 | SUPPL-18 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021540s018lbl.pdf | |
| 09/20/2007 | SUPPL-11 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s011lbl.pdf | |
| 09/20/2007 | SUPPL-9 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021540s009lbl.pdf | |
| 08/28/2006 | SUPPL-6 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s006lbl.pdf | |
| 04/13/2006 | SUPPL-8 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021540s008lbl.pdf | |
| 09/27/2004 | SUPPL-3 |
Labeling |
Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540s003lbl.pdf | |
| 01/30/2004 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21540_caduet_lbl.pdf |
CADUET
TABLET;ORAL; EQ 5MG BASE;EQ 10MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 5MG BASE;EQ 20MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 5MG BASE;EQ 40MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 5MG BASE;EQ 80MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 5MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 10MG BASE;EQ 10MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 10MG BASE;EQ 20MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 10MG BASE;EQ 40MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 10MG BASE;EQ 80MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 205199 | APOTEX |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 200465 | MYLAN |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 10MG BASE;EQ 80MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 2.5MG BASE;EQ 10MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 10MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 2.5MG BASE;EQ 20MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 20MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
TABLET;ORAL; EQ 2.5MG BASE;EQ 40MG BASE
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 203874 | DR REDDYS |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | No | AB | 207762 | ZYDUS PHARMS |
| CADUET | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | EQ 2.5MG BASE;EQ 40MG BASE | TABLET;ORAL | Prescription | Yes | AB | 021540 | PHARMACIA |
نظرات کاربران